Knight Therapeutics Inc. (TSX:GUD)

Knight Therapeutics Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	93.54	76.45	80.11	58.76	71.68	85.96
Short-Term Investments	16.61	24.64	92.73	96.61	87.1	63.54
Trading Asset Securities	11.03	13.14	-	14.5	26.83	10.65
Cash & Short-Term Investments	121.17	114.23	172.84	169.87	185.61	160.16
Cash Growth	4.08%	-33.91%	1.75%	-8.48%	15.89%	-60.56%
Accounts Receivable	125.82	127.78	105.2	88.72	94.89	55.39
Other Receivables	19.03	10.46	8.34	9.51	13.68	12.03
Receivables	144.85	138.24	113.53	98.23	114	69.96
Inventory	144.57	135.87	102.7	91.83	92.49	72.4
Prepaid Expenses	7.8	6.51	7.74	4.88	3.34	2.17
Other Current Assets	-	-	-	0.3	0.18	0.29
Total Current Assets	418.4	394.84	396.81	365.12	395.62	304.97
Property, Plant & Equipment	31.38	21.93	20.02	17.86	22.63	29.94
Long-Term Investments	69.82	79.48	103.43	116.36	152.33	174.23
Goodwill	98.53	89.98	86.48	79.84	82.27	75.4
Other Intangible Assets	344.86	379.51	283.61	289.96	338.78	350.3
Long-Term Deferred Tax Assets	26.32	26.92	21.25	19.39	9.31	2.05
Other Long-Term Assets	55.53	53.64	52.2	53.3	50.13	51.28
Total Assets	1,045	1,046	963.8	945.49	1,055	991.89

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	135.63	120.87	78.35	85.37	106.06	65.31
Short-Term Debt	-	0.19	2.12	0.61	1.61	9.19
Current Portion of Long-Term Debt	16.3	16.54	15.37	17.24	16.06	17.48
Current Portion of Leases	3.42	3.4	2.64	1.73	2.58	1.61
Current Income Taxes Payable	0.38	0.58	0.21	1.18	2.27	7.07
Other Current Liabilities	27.76	23.68	12.56	7.9	12.73	4.64
Total Current Liabilities	183.49	165.26	111.25	114.03	141.32	105.3
Long-Term Debt	6.83	51.17	25.9	44.02	52.4	9.27
Long-Term Leases	7.73	6.62	3.43	5.5	5.05	3.42
Long-Term Deferred Tax Liabilities	3.16	2.99	3.84	2.82	4.37	12.37
Other Long-Term Liabilities	45.04	52.99	24.27	32.26	25.85	19.52
Total Liabilities	246.25	279.03	168.69	198.62	228.98	149.87

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	526.08	530.14	534.27	540.05	599.06	628.85
Additional Paid-In Capital	32.44	32.45	25.71	25.99	23.66	21.78
Retained Earnings	157.2	148.94	154.79	150.89	161.76	191.65
Comprehensive Income & Other	82.88	55.74	80.34	29.95	41.38	-0.26
Total Common Equity	798.59	767.27	795.11	746.87	825.86	842.02
Shareholders' Equity	798.59	767.27	795.11	746.87	825.86	842.02
Total Liabilities & Equity	1,045	1,046	963.8	945.49	1,055	991.89

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	34.28	77.91	49.46	69.09	77.7	40.96
Net Cash (Debt)	86.9	36.32	123.38	108.18	123.08	119.2
Net Cash Growth	644.10%	-70.56%	14.04%	-12.10%	3.26%	-67.36%
Net Cash Per Share	0.87	0.36	1.22	1.01	1.07	0.96
Filing Date Shares Outstanding	98.23	98.03	100.05	101.17	110.13	117.03
Total Common Shares Outstanding	98.22	99.19	100.05	101.17	112.21	117.78
Working Capital	234.91	229.58	285.57	251.09	254.3	199.67
Book Value Per Share	8.13	7.74	7.95	7.38	7.36	7.15
Tangible Book Value	355.2	297.78	425.02	377.07	404.8	416.32
Tangible Book Value Per Share	3.62	3.00	4.25	3.73	3.61	3.53
Land	-	0.01	0.01	0.93	1.55	1.09
Buildings	-	16.61	18.5	9.84	14.56	7.69
Machinery	-	39.92	42.56	21.91	33.13	25.94

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 17, 2026

Data Sources Report a data error